Investor Relations.
Delivering Results.
Balchem has delivered consistent growth, healthy margins and strong cash flows, enabling reinvestment that positions us well for the future.
Making a Real Difference.
Balchem has been dedicated to making the world a healthier place since 1967 by delivering trusted, innovative, and science-based solutions for the health and nutritional needs of the world. Balchem became a public company in 1970 so almost all of our growth has been in the public eye. We have leading positions in growing, attractive markets and drive new demand through continuous innovation. We are well positioned for continued long-term growth.
Quick Numbers.
2023 Sales in millions$922.4
2023 Adj. EBITDA in millions$230.9
2023 Adj. EBITDA margin25.0%
2023 5-Year Sales CAGR7.5%
2023 Adj. EBITDA CAGR7.7%
2023 Cash Flow in millions$183.8
